"Dear Madam, Dear Sir, 

The year 2024 marked a decisive turning point for SMAIO, with the establishment of the company's general and sales management in the United States, in order to be at the heart of the world's leading market for spinal implants (70% of global value), and accelerate the Group's growth. The average quarterly increase in North American sales of over 60% for the year testifies to the relevance of this strategy, which is based on collaboration with a targeted number of centers of excellence, alongside the Group's historical centers in Europe. The establishment of SMAIO's North American Scientific Advisory Board, which will be expanded over the course of 2025, is further evidence of the company's determination to align its offering with the most ambitious US scientific and technological standards. With this in mind, SMAIO's strengths in data, artificial intelligence and spinal realignment give it a unique position among industry leaders and are attracting the interest of spinal deformity experts in the United States, as evidenced by the exponential growth in participation in its “Sagittal Alignment Think Tank” training programs. As a result, the United States now accounts for more than half of our business, and we are focusing most of our efforts on realizing this vision of a company combining the excellence and creativity of French engineering in the field of medical devices, with deep commercial and scientific roots in the United States, serving a group of leading American surgeons who share our philosophy. The year 2025 will be marked by our continued expansion in the United States. Our solutions will continue to be distributed directly, in proximity to American surgeons, and nationwide by our distribution partners, who are commissioned on sales. Given the very positive feedback from surgeons using our products, the enthusiastic reception of our offer by prospective customers, and our ongoing innovation, we believe we can rapidly position SMAIO on a profitable and sustainable growth trajectory, to make it a key international leader in the spinal realignment market .”

Philippe ROUSSOULY
Chairman and CEO